Extraintestinal Consequences of Mucosal Inflammation

Leonidas A. Bourikas, Konstantinos Papadakis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Constitutional symptoms such as fatigue, anorexia, fever and arthralgias are the result of the systemic effects ofproinflammatory cytokines produced in the IBD mucosa. Anemia frequently complicates the course of IBD and is usually multifactorial with iron deficiency, vitamin B12deficiency, anemia of inflammation, medications or combinations of these being the most common causes. IBD is characterized by a hypercoagulable state and patients are at risk of developing thromboembolic events. IBD carries a higher risk of hematologic malignancies, particularly lymphoma, in patients receiving immunosuppressiveor anti-TNF treatment. Amyloidosis may rarely complicate the course of IBD.

Original languageEnglish (US)
Title of host publicationInflammatory Bowel Disease
Subtitle of host publicationTranslating basic science into clinical practice
PublisherWiley-Blackwell
Pages195-211
Number of pages17
ISBN (Print)9781405157254
DOIs
StatePublished - May 18 2010
Externally publishedYes

Fingerprint

Anemia
Inflammation
Avitaminosis
Arthralgia
Anorexia
Amyloidosis
Hematologic Neoplasms
Fatigue
Lymphoma
Mucous Membrane
Fever
Iron
Cytokines
Therapeutics

Keywords

  • Acute phase proteins - 25% increase or decrease in plasma concentrations during inflammation
  • Amyloidosis in patients with IBD
  • Disorders of coagulation - one in 1000 people experiencing thrombotic episode
  • Extraintestinal consequences of mucosal inflammation
  • Hematologic consequences of intestinal inflammation
  • Hematologic malignancies - lymphoma, rheumatoid arthritis, sjögren syndrome or celiac disease
  • Leukocytosis - elevated leukocyte counts associated with increased risk of recurrence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bourikas, L. A., & Papadakis, K. (2010). Extraintestinal Consequences of Mucosal Inflammation. In Inflammatory Bowel Disease: Translating basic science into clinical practice (pp. 195-211). Wiley-Blackwell. https://doi.org/10.1002/9781444318418.ch14

Extraintestinal Consequences of Mucosal Inflammation. / Bourikas, Leonidas A.; Papadakis, Konstantinos.

Inflammatory Bowel Disease: Translating basic science into clinical practice. Wiley-Blackwell, 2010. p. 195-211.

Research output: Chapter in Book/Report/Conference proceedingChapter

Bourikas, LA & Papadakis, K 2010, Extraintestinal Consequences of Mucosal Inflammation. in Inflammatory Bowel Disease: Translating basic science into clinical practice. Wiley-Blackwell, pp. 195-211. https://doi.org/10.1002/9781444318418.ch14
Bourikas LA, Papadakis K. Extraintestinal Consequences of Mucosal Inflammation. In Inflammatory Bowel Disease: Translating basic science into clinical practice. Wiley-Blackwell. 2010. p. 195-211 https://doi.org/10.1002/9781444318418.ch14
Bourikas, Leonidas A. ; Papadakis, Konstantinos. / Extraintestinal Consequences of Mucosal Inflammation. Inflammatory Bowel Disease: Translating basic science into clinical practice. Wiley-Blackwell, 2010. pp. 195-211
@inbook{777fae8673d644429aa2d6621641a16b,
title = "Extraintestinal Consequences of Mucosal Inflammation",
abstract = "Constitutional symptoms such as fatigue, anorexia, fever and arthralgias are the result of the systemic effects ofproinflammatory cytokines produced in the IBD mucosa. Anemia frequently complicates the course of IBD and is usually multifactorial with iron deficiency, vitamin B12deficiency, anemia of inflammation, medications or combinations of these being the most common causes. IBD is characterized by a hypercoagulable state and patients are at risk of developing thromboembolic events. IBD carries a higher risk of hematologic malignancies, particularly lymphoma, in patients receiving immunosuppressiveor anti-TNF treatment. Amyloidosis may rarely complicate the course of IBD.",
keywords = "Acute phase proteins - 25{\%} increase or decrease in plasma concentrations during inflammation, Amyloidosis in patients with IBD, Disorders of coagulation - one in 1000 people experiencing thrombotic episode, Extraintestinal consequences of mucosal inflammation, Hematologic consequences of intestinal inflammation, Hematologic malignancies - lymphoma, rheumatoid arthritis, sj{\"o}gren syndrome or celiac disease, Leukocytosis - elevated leukocyte counts associated with increased risk of recurrence",
author = "Bourikas, {Leonidas A.} and Konstantinos Papadakis",
year = "2010",
month = "5",
day = "18",
doi = "10.1002/9781444318418.ch14",
language = "English (US)",
isbn = "9781405157254",
pages = "195--211",
booktitle = "Inflammatory Bowel Disease",
publisher = "Wiley-Blackwell",
address = "United States",

}

TY - CHAP

T1 - Extraintestinal Consequences of Mucosal Inflammation

AU - Bourikas, Leonidas A.

AU - Papadakis, Konstantinos

PY - 2010/5/18

Y1 - 2010/5/18

N2 - Constitutional symptoms such as fatigue, anorexia, fever and arthralgias are the result of the systemic effects ofproinflammatory cytokines produced in the IBD mucosa. Anemia frequently complicates the course of IBD and is usually multifactorial with iron deficiency, vitamin B12deficiency, anemia of inflammation, medications or combinations of these being the most common causes. IBD is characterized by a hypercoagulable state and patients are at risk of developing thromboembolic events. IBD carries a higher risk of hematologic malignancies, particularly lymphoma, in patients receiving immunosuppressiveor anti-TNF treatment. Amyloidosis may rarely complicate the course of IBD.

AB - Constitutional symptoms such as fatigue, anorexia, fever and arthralgias are the result of the systemic effects ofproinflammatory cytokines produced in the IBD mucosa. Anemia frequently complicates the course of IBD and is usually multifactorial with iron deficiency, vitamin B12deficiency, anemia of inflammation, medications or combinations of these being the most common causes. IBD is characterized by a hypercoagulable state and patients are at risk of developing thromboembolic events. IBD carries a higher risk of hematologic malignancies, particularly lymphoma, in patients receiving immunosuppressiveor anti-TNF treatment. Amyloidosis may rarely complicate the course of IBD.

KW - Acute phase proteins - 25% increase or decrease in plasma concentrations during inflammation

KW - Amyloidosis in patients with IBD

KW - Disorders of coagulation - one in 1000 people experiencing thrombotic episode

KW - Extraintestinal consequences of mucosal inflammation

KW - Hematologic consequences of intestinal inflammation

KW - Hematologic malignancies - lymphoma, rheumatoid arthritis, sjögren syndrome or celiac disease

KW - Leukocytosis - elevated leukocyte counts associated with increased risk of recurrence

UR - http://www.scopus.com/inward/record.url?scp=84886037489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886037489&partnerID=8YFLogxK

U2 - 10.1002/9781444318418.ch14

DO - 10.1002/9781444318418.ch14

M3 - Chapter

AN - SCOPUS:84886037489

SN - 9781405157254

SP - 195

EP - 211

BT - Inflammatory Bowel Disease

PB - Wiley-Blackwell

ER -